ABZU
Bring drugs to market, faster
Abzu drives new discoveries and reduces R&D costs for biotech and pharma.
Clients we are proud to disclose
ACCELERATING DRUG DEVELOPMENT
Abzu closes the drug and target discovery loop
Disease mechanisms
Understand the basis of disease, and identify novel points of intervention.
Lead discovery
Determine the underlying mechanisms to optimize high-throughput screening.
Preclinical and clinical
Reveal drug-target interaction signatures from in vivo, in vitro, and in silico data.
Lead optimization
Improve hit-rate by explaining selectivity, toxicity, and activity drivers.
Umut Eser,
CIO
Morten Lindow,
Therapeutic Modalities
Michael Christiansen
Chief Physician
Afshin Beheshti,
President
Abzu recognized as a Cool Vendor in artificial intelligence
Abzu is named a “Cool Vendor” in the 2022 Gartner® “AI Governance and Responsible AI — From Principles to Practice” report.
Abzu accelerates scientific research
What makes Abzu unique?
Abzu was born from the desire to challenge the fundamental assumptions of contemporary, black-box AI. Watch Abzu’s story in 3 minutes.
Contact Abzu
It’s easy to get in touch with an Abzoid.
Contact form
Fill out the form below, and an Abzoid will be in touch in 24 hours.
Email us
Contact Sales at sales@abzu.ai or a scientist at science@abzu.ai.